Updates on the Treatment Approach for MCL

 

T

Targeting and Treatment of MCL

By Thomas McFarlane
92 views
April 25, 2023
0 Comments
Login to view comments. Click here to Login
Updates on the Treatment Approach for MCL
09:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Outcomes of Adults With R/R B-A…

Feat. B. Shah
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
09:45
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …

Feat. M. Kamdar
34:28
Indy Hematology Review

Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas

Feat. T. Phillips
07:08
VCU Massey Cancer Center

Recent Advances in the Treatment of MCL

Feat. V. Yazbeck
38:55
Indy Hematology Review

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Feat. G. Salles
10:51
Kami Maddocks

Sequencing Treatment for R/R MCL

29:22
UChicago Medicine

Updates on MCL and CAR-T

Feat. P. Riedell
09:00
Thomas McFarlane

Targeting and Treatment of MCL

24:04
Yale Cancer Center

Updates on Allogeneic Stem Cell Transplant

Feat. L. Bachegowda
11:19
The University of Alabama at Birmingham School of Medicine

Mantle Cell Lymphoma: Unmet Needs & Latest Therapeutical Insights

Feat. A. Mehta
12:54
The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…

Feat. M. Narkhede
15:01
Yazeed Sawalha

Novel Combinations for the Treatment of Patients With R/R MCL: Promi…

19:16
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Chemo and Non-Chemo Treatment of Mantle Cell Lymphoma

Feat. M. Wang
09:47
Icahn School of Medicine at Mount Sinai

What's the Difference? Covalent vs. Non-Covalent BTKis in MCL

Feat. J. Brody
05:24
Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…

25:29
19th Annual International Ultmann Chicago Lymphoma Symposium

Mantle Cell Lymphoma: Case-Based Approach to Management

Feat. R. Karmali
07:11
Lauren Pinter-Brown

Disease Progression in Mantle Cell Lymphoma

07:48
City of Hope

Tolerability of BTKi in R/R MCL

Feat. T. Phillips
10:36
ASH 2022 Conference Coverage

The CAR-HEMATOTOX Score Identifies Patients at High Risk for Hematol…

Feat. K. Rejeski
12:42
University of Colorado Cancer Center

Management of Patients With R/R MCL

Feat. M. Kamdar
06:35
ASH 2022 Conference Coverage

Results From a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-…

Feat. N. Shah
08:54
ASH 2022 Conference Coverage

ECOG-ACRIN E1411: A Randomized Phase 2 Trial of First-Line Bendamust…

Feat. M. Smith
06:16
City of Hope

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

Feat. A. Danilov